Research progress on the association between viruses and cardiac diseases
Journal of Virology · 2026
DOI: 10.1128/jvi.00383-26 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Virology, 2026. Verfasst von He-Min Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: Heart Diseases, Virus Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yunnan Science and Technology Talent and Platform Program, Yunnan Provincial Science and Technology Department, Yunnan Key Research and Development Program.
Abstract (Originalsprache)
Virus-related cardiac diseases encompass a diverse spectrum of cardiovascular pathologies caused by direct viral infection and indirect immune-mediated injury. Major cardiotropic and cardioactive viruses—including severe acute respiratory syndrome coronavirus 2, influenza virus, human immunodeficiency virus, arboviruses (dengue virus, chikungunya virus, Zika virus), enteroviruses (coxsackievirus B3), and human cytomegalovirus—contribute to myocardial injury manifesting as myocarditis, pericarditis, arrhythmias, acute and chronic heart failure, and thromboembolic complications. Mechanisms of cardiac involvement are multifactorial, involving direct infection of cardiac cells leading to cytopathic effects and innate immune activation, dysregulated adaptive immune responses promoting myocardial inflammation and fibrosis, electrophysiological disturbances, and systemic effects such as endothelial dysfunction and prothrombotic states that precipitate ischemic events. Clinical manifestations range from subclinical injury to fulminant myocardial inflammation and may also include long-term sequelae, such as post-acute cardiovascular symptoms, as observed in long COVID cases. Therapeutic strategies emphasize early antiviral treatment when effective agents exist, judicious immunomodulation based on viral replication status, and supportive management of cardiac dysfunction and arrhythmias. Prevention through vaccination, personal protective measures, vector control, and optimization of cardiovascular risk factors remains pivotal to reduce the burden of virus-associated cardiovascular diseases. Future research requires improved diagnostic precision, mechanistic elucidation, and randomized trials to optimize antiviral and immunomodulatory interventions and to develop vaccines for currently unmet viral targets. An integrated, mechanism-informed approach across prevention, acute management, and long-term care is essential to mitigate the cardiovascular morbidity and mortality attributable to viral infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan, China.
- Yunnan Key Laboratory of Cross-Border Infectious Disease Control and Prevention and Novel Drug Development, Kunming Medical University, Kunming, Yunnan, China.
- Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
ORCID-Profile: Ming-Liang Zhu, Pan-Pan Pang, Chang-Bo Zheng
Förderung
- Yunnan Science and Technology Talent and Platform Program
- Yunnan Provincial Science and Technology Department
- Yunnan Key Research and Development Program
- Program Innovative Research Team in Science and Technology in Kunming Medical University
- Science and Technology Projects of Yunnan Universities Serving Key Industries
- First-Class Discipline Team of Kunming Medical University
- Yunnan Talent Suppot Plant
- Graduate Student Innovation Foundation of Kunming Medical University
Zitieren
APA
Yu, H. M., Zhu, M. L., Zhao, Y. L., Tan, J. X., Luo, S. C., Pang, P. P., & Zheng, C. B. (2026). Research progress on the association between viruses and cardiac diseases. Journal of Virology. https://doi.org/10.1128/jvi.00383-26
Vancouver
Yu HM, Zhu ML, Zhao YL, Tan JX, Luo SC, Pang PP, et al. Research progress on the association between viruses and cardiac diseases. Journal of Virology. 2026. doi:10.1128/jvi.00383-26
BibTeX
@article{Yu2026,
author = {Yu, He-Min and Zhu, Ming-Liang and Zhao, Yan-Li and Tan, Jia-Xiang and Luo, Shao-Chao and Pang, Pan-Pan and Zheng, Chang-Bo},
title = {Research progress on the association between viruses and cardiac diseases},
journal = {Journal of Virology},
year = {2026},
doi = {10.1128/jvi.00383-26}
}
EUVIMED